Coronary heart disease: Significance of liver X receptor alpha genomics

被引:4
作者
Dave, Vivek Priy [1 ]
Kaul, Deepak [1 ]
机构
[1] Post Grad Inst Med Educ & Res, Dept Expt Med & Biotechnol, Chandigarh 160012, India
关键词
Coronary heart disease; Liver X receptor; Lipid metabolism; Inflammation;
D O I
10.4330/wjc.v2.i6.140
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Crosstalk between lipid peroxidation and inflammation is known to be a pathognomonic feature for the development of coronary heart disease (CHD). In this regard ligand activated liver X receptor (LXR)-alpha has emerged as a key molecular switch by its inherent ability to modulate an array of genes involved in these two fundamental cellular processes. In addition, LXR-alpha has also been found to play a role in hepatic lipogenesis and innate immunity. Although several lines of evidence in experimental model systems have established the atheroprotective nature of LXR-alpha, human subjects have been reported to possess a paradoxical situation in which increased blood cellular LXR-alpha gene expression is always accompanied by increased coronary occlusion. This apparent paradox was resolved recently by the finding that CHD patients possess a deregulated LXR-alpha transcriptome due to impaired ligand-receptor interaction. This blood cellular mutated LXR- a gene expression correlated specifically with the extent of coronary occlusion and hence need is felt to devise new synthetic ligands that could restore the function of this mutated LXR-alpha protein in order to modulate genes involved in reverse cholesterol transport and suppression of the inflammatory response leading to the effective treatment of CHD. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:140 / 149
页数:10
相关论文
共 104 条
[1]
A NOVEL ORPHAN RECEPTOR-SPECIFIC FOR A SUBSET OF THYROID HORMONE-RESPONSIVE ELEMENTS AND ITS INTERACTION WITH THE RETINOID/THYROID HORMONE-RECEPTOR SUBFAMILY [J].
APFEL, R ;
BENBROOK, D ;
LERNHARDT, E ;
ORTIZ, MA ;
SALBERT, G ;
PFAHL, M .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (10) :7025-7035
[2]
A role for the apoptosis inhibitory factor AIM/Spα/Api6 in atherosclerosis development [J].
Arai, S ;
Shelton, JM ;
Chen, MY ;
Bradley, MN ;
Castrillo, A ;
Bookout, AL ;
Mak, PA ;
Edwards, PA ;
Mangelsdorf, DJ ;
Tontonoz, P ;
Miyazaki, T .
CELL METABOLISM, 2005, 1 (03) :201-213
[3]
Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition [J].
Argmann, CA ;
Edwards, JY ;
Sawyez, CG ;
O'Neil, CH ;
Hegele, RA ;
Pickering, JG ;
Huff, MW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (23) :22212-22221
[4]
Importance of blood cellular genomic profile in coronary heart disease [J].
Baba, MI ;
Kaul, D ;
Grover, A .
JOURNAL OF BIOMEDICAL SCIENCE, 2006, 13 (01) :17-26
[5]
Berge KE, 2002, J LIPID RES, V43, P486
[6]
Oxysterols in human circulation:: which role do they have? [J].
Björkhem, I ;
Meaney, S ;
Diczfalusy, U .
CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (03) :247-253
[7]
Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries [J].
Blaschke, F ;
Leppanen, O ;
Takata, Y ;
Caglayan, E ;
Liu, J ;
Fishbein, MC ;
Kappert, K ;
Nakayama, KI ;
Collins, AR ;
Fleck, E ;
Hsueh, WA ;
Law, RE ;
Bruemmer, D .
CIRCULATION RESEARCH, 2004, 95 (12) :E110-E123
[8]
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].
Bodzioch, M ;
Orsó, E ;
Klucken, T ;
Langmann, T ;
Böttcher, L ;
Diederich, W ;
Drobnik, W ;
Barlage, S ;
Büchler, C ;
Porsch-Özcürümez, M ;
Kaminski, WE ;
Hahmann, HW ;
Oette, K ;
Rothe, G ;
Aslanidis, C ;
Lackner, KJ ;
Schmitz, G .
NATURE GENETICS, 1999, 22 (04) :347-351
[9]
Endothelial dysfunction - A marker of atherosclerotic risk [J].
Bonetti, PO ;
Lerman, LO ;
Lerman, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :168-175
[10]
Mammalian ABC transporters in health and disease [J].
Borst, P ;
Elferink, RO .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :537-592